Product Program year 2024 Source: CMS Open Payments

BD Nexiva

Device Vascular Access Devices

PDI 30382903835202

Open in the dashboard

General payments

$7,846

59 payments

Research payments

$0

0 payments

Through program year 2024, $7,846 in general payments and $0 in research payments were reported against BD Nexiva (Vascular Access Devices).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2024 General $5,669 31
2023 General $2,177 28

Breakdown

Who paid General payments · program years 2023–2024
  1. Becton, Dickinson and Company $7,846 59 payments
Top recipients General payments · program year 2024
  1. Barbara Nickel Kimball, NE $3,470 61% · 10 payments
  2. Louis A. Weiss Memorial Hospital Teaching hospital · IL $762 13% · 1 payment
  3. Michele Biscossi Nurse Practitioner, Acute Care · Saratoga Springs, NY $308 5% · 1 payment
  4. Stephanie Intorcia Nurse Practitioner · Macon, GA $180 3% · 1 payment
  5. Kathy Speigel Nurse Practitioner, Primary Care · Oklahoma City, OK $110 2% · 1 payment

The top 5 of 21 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Nurse Practitioner, Acute Care Nurse Practitioner $308 23% · 1 practitioner
  2. Nurse Practitioner $303 22% · 3 practitioners
  3. Clinical Nurse Specialist, Acute Care Clinical Nurse Specialist $110 8% · 1 practitioner
  4. Nurse Practitioner, Primary Care Nurse Practitioner $110 8% · 1 practitioner
  5. Nurse Practitioner, Family Nurse Practitioner $109 8% · 4 practitioners

The top 5 of 13 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Nebraska $3,470 61% · 1 recipient
  2. Illinois $762 13% · 1 recipient
  3. New York $308 5% · 1 recipient
  4. Oklahoma $220 4% · 2 recipients
  5. California $199 4% · 3 recipients

The top 5 of 14 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

59 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record